SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
ESS Tech announced a strategic pivot to accelerate sodium-ion battery development with early-stage opportunities approaching $1 billion, while streamlining Wilsonville operations, reducing expenses and headcount, and reallocating capital from iron flow battery development to sodium-ion solutions.
View raw filing on EDGAR →This Item 7.01 disclosure concerns Greenland Energy's updated investor presentation detailing its Jameson Land Basin exploration opportunity, drilling program (OPW-1 and OPW-6), prospective resource estimates, infrastructure mobilization, and operational milestones. While the presentation includes forward-looking statements and risk disclosures typical of early-stage exploration companies, the core event is the furnishing of an operational and strategic business communication—not a specific financial, governance, or legal event. The disclosure is material to investors assessing the company's exploration strategy and near-term execution plans, but does not fit narrower categories like earnings release, M&A activity, or material litigation.
View raw filing on EDGAR →The disclosure announces that the Department of Health – Abu Dhabi has granted Investigational New Drug (IND) status for NEO100, the Company's lead candidate. This is a material regulatory milestone that expands the Company's clinical development footprint internationally and enables advancement of multiple stages of clinical development in parallel across three protocols. While this is a significant operational and regulatory achievement for a clinical-stage biopharmaceutical company, it does not fit neatly into the specific event categories (it is not an earnings release, M&A activity, impairment, litigation, or other named types), making it an operational_other event that would materially affect a reasonable investor's assessment of the registrant's development progress.
View raw filing on EDGAR →The disclosure reports a Minnesota Public Utilities Commission verbal decision on NSP-Minnesota's 2024 electric rate case, approving an estimated $211 million rate increase over two years with an ROE of 9.60% and continuation of existing true-up mechanisms. This is a material regulatory milestone affecting the company's revenue and earnings, but does not fit the specific categories of earnings release, debt issuance, covenant breach, or other named financial/legal events. It is a significant operational and regulatory outcome that would affect investor assessment of the registrant's financial prospects.
View raw filing on EDGAR →SPS filed a comprehensive non-unanimous stipulation with the NMPRC on June 22, 2026, resolving its November 2025 electric rate case. The stipulation provides for a $90 million base rate revenue increase (7.7% total), an ROE of 9.5%, and an equity ratio of 54.70%, with NMPRC decision anticipated in Q4 2026. This is a material regulatory milestone affecting SPS's revenue and cost recovery, but it does not fit the specific categories of debt issuance, dividend distribution, workforce reduction, or material litigation—it is a significant operational and regulatory event that warrants disclosure under Item 8.01.
View raw filing on EDGAR →CMB.TECH and Fortescue have signed a milestone agreement for charter of up to 12 ammonia-capable Newcastlemax vessels, with three expected to be delivered with dual-fuel ammonia engines by end of 2026 and nine ammonia-ready for future conversion. This is a material operational and strategic partnership announcement involving a significant fleet commitment (12 vessels, 210,000 dwt each) that advances the company's decarbonization strategy and market positioning in zero-emissions shipping, but does not constitute a discrete M&A transaction, debt issuance, or other specifically-defined event type.
View raw filing on EDGAR →Sky Quarry announced that its Eagle Springs/Foreland Refinery is entering the production phase with operations expected to commence in July 2026, representing a material transition from development and infrastructure repair to active commercial refining operations and a fundamental inflection point in the company's evolution.
View raw filing on EDGAR →uniQure announced preliminary Phase I/IIa clinical trial data for AMT-260 in refractory mesial temporal lobe epilepsy, showing that 3 of 6 patients achieved meaningful seizure reductions (79-100% decline) with no serious adverse events and favorable tolerability. This represents a material clinical development milestone for the company's gene therapy pipeline.
View raw filing on EDGAR →Traws Pharma announced its intention to resubmit an updated toxicology data package to the UK's MHRA for tivoxavir marboxil (TXM), a clinical-stage antiviral candidate, to enable a Phase 2a human influenza challenge study to proceed. This is a material regulatory and operational milestone for a clinical-stage biopharmaceutical company—the resubmission and anticipated MHRA approval are critical to advancing the company's lead program. While not a specific named event type, this disclosure centers on a material operational/regulatory development affecting the company's clinical pipeline and strategy.
View raw filing on EDGAR →Definium announced positive topline results from its Phase 3 Emerge study of DT120 ODT for major depressive disorder, meeting the primary endpoint with an 8.1-point placebo-adjusted MADRS improvement (p<0.0001) and demonstrating rapid, durable efficacy with a favorable safety profile. This represents a material clinical development milestone advancing the company's late-stage program toward potential FDA submission.
View raw filing on EDGAR →Manchester United announced the acquisition of a 25-acre site to build a new 100,000-seat stadium, described as a "major milestone" and "generational opportunity." This is a material strategic and operational development involving significant capital commitment and long-term business transformation. While not fitting the specific categories of M&A (which typically involve acquisition of another company), it represents a major operational and capital project that would affect a reasonable investor's assessment of the club's strategic direction and financial obligations.
View raw filing on EDGAR →Apogee entered into two material agreements with Paragon on June 17, 2026: an antibody discovery agreement and an exclusive worldwide license agreement for IL-31R antibodies. The license agreement grants Apogee exclusive rights to develop and commercialize IL-31R-directed antibodies with up to $23.25 million in milestone payments and low-single-digit royalties on net sales. While this is a material contract that would affect a reasonable investor's assessment of the company's pipeline and strategic partnerships, it does not fit the specific M&A, financing, or governance categories—it is a research and development partnership and licensing arrangement that is operational in nature.
View raw filing on EDGAR →BrainsWay announced expansion of insurance coverage for its SWIFT Accelerated Deep TMS protocol, with eight major payers and the VA now covering the treatment, representing over 57 million covered lives. This is a material operational/commercial milestone reflecting improved market access and reimbursement for the company's core product, but does not fit the specific event categories (not earnings, M&A, litigation, or other named types). The expansion of favorable coverage policies is a significant business development that would affect investor assessment of the company's commercial prospects.
View raw filing on EDGAR →This press release discloses exploration drilling results at Alamos Gold's Island Gold District, reporting new high-grade mineralization zones and extensions across multiple targets (Island West Extension, Island West up-plunge, NS1/NS4 zones, Cline-Pick, Edwards mines). The company budgeted $43 million for 2026 exploration and reports 50,000 m of planned underground drilling. While the results describe potential sources of additional mill feed and production growth, this is an operational/exploration milestone rather than a discrete event fitting other categories. The disclosure is material as it describes significant exploration upside that could affect investor assessment of the company's growth prospects and reserve base.
View raw filing on EDGAR →OPC Energy Ltd., a Kenon subsidiary, has received tariff approval from the Israeli Electricity Authority for the Hadera power plant expansion project (850 MW combined-cycle natural gas facility) and confirmation that the project satisfies conditions for financial closing. This is a material operational and regulatory milestone for a major capital project, but does not fit the discrete event categories (M&A, debt issuance, impairment, etc.); it is a strategic business development—regulatory approval enabling project advancement—best classified as operational_other.
View raw filing on EDGAR →RTB Digital announced the launch of a real-time, AI/DeFi payment platform for professional publishers, enabling instant USDC settlement of ad revenue through Coinbase integration and a proprietary Media Liquidity Pool. This material product launch and strategic operational milestone affects the company's core business model and competitive positioning in the media technology industry.
View raw filing on EDGAR →MapLight disclosed topline results from the Phase 2 IRIS trial of ML-004 in autism spectrum disorder on June 22, 2026. The trial did not meet its primary endpoint for social communication deficits but showed clinically meaningful improvement in irritability in adolescents with moderate-to-severe baseline irritability, with effect sizes comparable to approved antipsychotics.
View raw filing on EDGAR →TScan announced positive initial data from Cohort C of its Phase 1 ALLOHA™ study evaluating TSC-101, including manufacturing success rates, patient enrollment, chimerism outcomes, and safety results, with confirmation that the company remains on track to initiate a Phase 3 pivotal study. This represents a material clinical development milestone for the company's lead product candidate.
View raw filing on EDGAR →Brazil Potash announced the award of a second FEED (Front-End Engineering Design) contract to WSP UK Ltd. and Redpath Deilmann for mine shafts and underground development at the Autazes Project. This completes full-project FEED coverage and is material because it represents a critical milestone toward construction debt financing with Development Finance Institutions and Export Credit Agencies. The contract value is estimated at USD 26 million (with USD 4.3 million awarded for the initial Early Works phase), and the disclosure emphasizes that shaft sinking constitutes the critical path defining the entire project construction schedule. This is a material operational/strategic milestone for the development project, not a discrete event fitting other categories.
View raw filing on EDGAR →Taysha announced completion of dosing in the REVEAL pivotal trial for TSHA-102 and reported positive longer-term clinical data from Part A, including 100% of patients gaining/regaining developmental milestones and 310 total functional gains at ≥12 months post-treatment, representing a material clinical and regulatory milestone advancing toward BLA submission in 1H 2027.
View raw filing on EDGAR →This press release announces FDA accelerated approval of Tzield (teplizumab-mzwv) for a new indication—delaying decline in endogenous insulin production in children aged 8–17 with recently diagnosed stage 3 type 1 diabetes. The approval is a significant regulatory and commercial milestone for Sanofi's pipeline, expanding the drug's approved indications and market opportunity. While not a discrete M&A, debt, or capital event, the regulatory approval of a first-in-class disease-modifying therapy for a new patient population is a material operational and strategic development that would affect a reasonable investor's assessment of the company's product portfolio and revenue prospects.
View raw filing on EDGAR →First Tracks entered into a 12-month sublease for approximately 45,057 square feet of office space in San Diego on June 15, 2026. While disclosed under Item 1.01 (Material Definitive Agreement), this is a real estate lease arrangement rather than an acquisition, disposition, merger, or change of control. The sublease is material to investors as it represents a significant operational commitment (45,000+ sq ft facility) and ongoing financial obligation, but it is fundamentally an operational/strategic business arrangement rather than a transaction fitting the M&A taxonomy. Classified as operational_other because the event is clearly operational (facility lease) but does not fit the specific M&A categories that Item 1.01 typically covers.
View raw filing on EDGAR →Spero Therapeutics announced FDA approval of Utebzi (tebipenem pivoxil), the company's lead product candidate for complicated urinary tract infections and the first-and-only oral carbapenem antibiotic approved in this indication. This represents a major regulatory milestone and transition from development to commercialization, materially affecting the company's commercial prospects and future revenue potential.
View raw filing on EDGAR →This Item 7.01 disclosure is a shareholder letter from Apollo Debt Solutions BDC reporting quarterly performance metrics (net total return of +1.4% for the quarter, 1.5% year-to-date), investor flows ($0.3B gross inflows in Q2, $1.0B year-to-date), redemption activity (16.8% redemption requests, 5% honored), portfolio composition and credit quality metrics, and strategic positioning in the direct lending market. While it contains performance data, the disclosure is primarily operational and strategic in nature—discussing market conditions, capital deployment, portfolio health, and competitive positioning—rather than constituting a formal earnings release or financial results announcement. The material information about net outflows (~$0.4B, 3% of NAV) and redemption trends would affect investor assessment of the fund's capital flows and stability.
View raw filing on EDGAR →GCL's publishing subsidiary 4Divinity has secured exclusive worldwide publishing and distribution rights for the action-RPG "A Whisper of Fall: Jinyiwei" from Chengdu Cangmo. This represents a material strategic business partnership and content acquisition that expands 4Divinity's portfolio with a premium IP title planned for global launch in 2027. While not a traditional M&A transaction, the exclusive publishing agreement is a significant operational and commercial milestone for the company's gaming business.
View raw filing on EDGAR →MoonLake disclosed Week 52 Phase 3 VELA trial results for sonelokimab in hidradenitis suppurativa, showing 67.2% HiSCR75 response and 26.0% inflammatory remission, along with interim Week 24 adolescent data (~68% HiSCR75 response). The company announced plans to submit a Biologics License Application (BLA) to the FDA by end of September 2026, representing a material clinical development milestone with significant regulatory and commercial implications.
View raw filing on EDGAR →This press release announces the successful completion of Part A treatment for all 24 participants in Clearmind's Phase I/II clinical trial of CMND-100 for Alcohol Use Disorder. The company states it is "currently assessing the dataset and, assuming results remain favorable, intends to initiate the next stage of the clinical program." This is a material clinical development milestone for a clinical-stage biotech company, but it is not a discrete earnings release (no financial results disclosed), nor does it fit other specific event categories. It represents a significant operational/clinical progress event that would affect a reasonable investor's assessment of the company's pipeline advancement.
View raw filing on EDGAR →Getty Images announced a multi-year display partnership with OpenAI under which Getty Images' licensed content will appear in ChatGPT's search and discovery experiences. This is a material strategic partnership involving a major technology platform that enhances Getty's distribution and monetization of its content library. While not a traditional M&A transaction, it represents a significant operational and commercial arrangement that would affect investor assessment of the company's growth prospects and competitive positioning in the AI era.
View raw filing on EDGAR →ArcelorMittal announces a strategic collaboration with AWS to deploy cloud, AI, and edge technologies across its manufacturing operations, plus a multi-year supply framework agreement with Amazon for lower-carbon XCarb® steel. This is a material operational and commercial partnership involving digital transformation at scale and a significant supply contract, but it does not fit the discrete event categories (not M&A, not a debt/equity issuance, not a workforce reduction). The collaboration and supply agreement represent a strategic business initiative that would affect investor assessment of the company's operational modernization and commercial positioning.
View raw filing on EDGAR →This news release announces Silvercorp's construction plan and budget (US$196.3 million) for the development of the Chaarat ZAAV gold project in Kyrgyzstan, including Phase 1 (Tulkubash) and Phase 2 (Kyzyltash) with detailed timelines and spending forecasts through 2028. This is a material operational and strategic milestone—a major capital project development announcement—that does not fit the specific event categories (M&A, impairment, debt issuance, etc.) but clearly affects the registrant's operational direction and capital allocation strategy.
View raw filing on EDGAR →Petrobras announced Board approval of a Final Investment Decision (FID) for a US$1.2 billion biorefining project at its Presidente Bernardes Refinery to produce bio-jet fuel and renewable diesel with 15,000 bpd capacity by 2030. This is a material capital investment and strategic operational commitment aligned with the company's Business Plan 2026–2030 and energy transition strategy, but does not constitute a discrete M&A transaction, debt issuance, or other specifically-named event type—it is a major capital project approval and operational/strategic initiative.
View raw filing on EDGAR →Fluent announced the launch of "Fluent In-Store," a new commerce media offering for physical retail environments built on a partnership with Bilt Technologies and deploying at Beyond, Inc. locations. This is a material operational and strategic business development—a new product line and market expansion—that does not fit a more specific category. The disclosure is made under Regulation FD (Item 7.01), indicating it is material information being disclosed to investors.
View raw filing on EDGAR →Genprex announced a Canadian patent allowance for Reqorsa® in combination with PD-1/PD-L1 antibodies for lung cancer treatment, expanding its intellectual property portfolio across multiple jurisdictions. While patent issuances are typically routine, this disclosure emphasizes the strategic importance of IP protection for the Acclaim-3 clinical trial and the company's competitive positioning in oncology, making it a material operational/strategic milestone rather than a routine administrative matter.
View raw filing on EDGAR →The filing discloses completion of a U.S. redomicile (corporate domicile change), commencement of drilling operations at multiple prospects (Stibium antimony and RPM gold), completion of a major geophysical survey (ZTEM), and advancement of site infrastructure and equipment procurement for antimony production. While the redomicile is a governance/structural event, the press release emphasizes operational milestones—drilling, exploration, and development activities—making this primarily an operational disclosure. The material nature is supported by the scale of activities (multiple drill rigs, US$43.4M DoD funding, 200+ square mile project) and the CEO's characterization of a "transformational period."
View raw filing on EDGAR →The filing discloses three operational developments: achievement of 35% gross margin in May 2026 (up 660 basis points from Q1), securing Meyer Distributing as a new national B2B distribution partner, and targeting $36M+ annualized revenue opportunity. These represent material operational and commercial milestones—margin expansion, distribution scale, and revenue trajectory—that would affect a reasonable investor's assessment of the company's operational progress and cash-flow path toward profitability. While the filing is structured as a Regulation FD disclosure (Item 7.01) via press release, the substance is operational/strategic rather than fitting a specific named category like earnings_release (no full financial results), ma_activity (no acquisition/merger), or debt_issuance.
View raw filing on EDGAR →LifeMD announced a strategic co-marketing collaboration with Halozyme's subsidiary Antares Pharma to launch an exclusive telehealth program for XYOSTED (testosterone enanthate) injection, launching July 2026 in 37 states. The company will serve as the exclusive telehealth co-marketing partner, provide clinical evaluation through its medical group, and operate as the preferred dispensing pharmacy. This is a material operational and commercial partnership that expands LifeMD's service offerings and revenue opportunities, but does not fit the specific categories of M&A activity, debt issuance, or other named financial/governance events.
View raw filing on EDGAR →Cheche Group announced the commercial launch of "ABAO Agent," an AI-powered intelligent underwriting solution that represents a strategic evolution from a digital insurance transaction platform to an AI-driven insurtech company. The announcement describes autonomous capabilities deployed at scale in auto insurance renewal workflows, positioning this as a material operational and strategic milestone. While not a discrete M&A, executive change, or financial event, the launch of a proprietary AI product that the CEO characterizes as "the core engine of Cheche's intelligent transformation" and a "competitive moat" would affect a reasonable investor's assessment of the company's strategic direction and competitive positioning.
View raw filing on EDGAR →CIMG Inc. announced that its subsidiary Zhongyan Shangyue entered into a framework contract with Zhongshishun for construction and operation of a computing power center in Beijing, with a total contract value of up to USD 442 million over two years. This is a material operational/strategic business event involving a significant new business line (computing power services) and substantial contract value. However, the filing explicitly cautions that "there can be no assurance that the proposed project will be implemented in whole or in part" and that implementation is "subject to further arrangements, purchase orders, work orders, definitive agreements and/or satisfaction of other conditions," which introduces execution risk. The event is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated M&A or contract Item, and the framework nature (rather than definitive agreement) suggests this is a preliminary arrangement rather than a binding commitment.
View raw filing on EDGAR →The company disclosed a NI 43-101 Technical Report describing material non-operating trona royalty interests held through Sweetwater Entities in the Green River Basin, Wyoming, including geological, operational, and economic characteristics of multiple operating soda ash mines and greenfield projects that would be acquired upon completion of the proposed business combination.
View raw filing on EDGAR →Strive announced a bitcoin purchase of 759 BTC at approximately $65,850 per bitcoin during June 15-21, 2026, along with updates to its treasury holdings (cash, bitcoin, and STRC Stock) and share counts. This represents a material operational/strategic decision to deploy capital into digital assets as part of the company's stated bitcoin treasury strategy, but does not fit neatly into the specific financial event categories (debt issuance, dividend, impairment, etc.). The disclosure is clearly material to investors assessing the company's capital allocation and strategic direction, particularly given the forward-looking statements referencing "Bitcoin treasury strategies" and their risks.
View raw filing on EDGAR →Harmony disclosed a fatal workplace incident at its Moab Khotsong mine on June 19, 2026 — an employee died in a seismicity-related fall-of-ground incident. While the company's safety record and operational risks are material to investors, this specific incident does not fit the named categories (it is not a workforce reduction/restructuring, litigation, or regulatory investigation per se, though an investigation by the Department of Mineral and Petroleum Resources is underway). The disclosure is clearly operational and material to a reasonable investor assessing the registrant's safety practices and operational risk, but the event itself is best classified as an operational incident rather than a specific named type.
View raw filing on EDGAR →Gold Fields discloses an ongoing material operational and regulatory matter: the renewal process for five Tarkwa mining leases due in April 2027, with early application submitted in November 2025 and ongoing engagements with the Government of Ghana focused on renewal terms. While the outcome remains uncertain, the Tarkwa mine is a material operating asset, and lease renewal is a critical operational milestone that would affect investor assessment of the company's ability to continue operations at this location. This is neither a discrete event (M&A, impairment, litigation) nor a periodic report, but rather a material operational/regulatory development requiring disclosure.
View raw filing on EDGAR →Praxis announced FDA Breakthrough Therapy Designation for elsunersen (PRAX-222) for SCN2A-DEE, supported by positive Phase 1/2 trial results. This is a material regulatory milestone that accelerates development and review timelines for a lead candidate, directly affecting the company's clinical and commercial prospects. While not fitting a specific named category, this is clearly an operational/strategic event material to investors assessing the registrant's pipeline progress.
View raw filing on EDGAR →The Company reported its net asset value per share of $20.03 as of May 31, 2026, and provided a status update on its ongoing private offering of Common Stock, noting cumulative issuances of 145.76 million shares and total consideration received of $3.0 billion toward a $4.5 billion target.
View raw filing on EDGAR →This exhibit announces the live integration of Houdini Swap (SOL Strategies' wholly-owned privacy-focused cross-chain swap aggregator) with Jumper, a major multi-chain aggregation platform processing over $1 billion in monthly volume. The disclosure highlights a significant distribution partnership and product milestone—Houdini's API is now embedded in Jumper's routing infrastructure, extending access to Houdini's private transaction functionality to hundreds of thousands of Jumper users. While not a traditional M&A, contract, or regulatory milestone, this represents a material operational and strategic advancement for the company's core business, warranting classification as an operational event rather than a more specific category.
View raw filing on EDGAR →This press release announces final results from a Grade Control drilling program at Mayfair's Fenn-Gib Project, validating the mineral reserve model and confirming ore-grade material characteristics. The disclosure is material to investors as it de-risks the project by confirming reserve estimates, validates early-years high-grade feed availability, and supports project financing discussions—all critical milestones for a development-stage gold company advancing toward 2028 construction. However, it does not fit neatly into standard event categories (not earnings, M&A, impairment, or litigation), making it an operational/strategic milestone best classified as operational_other.
View raw filing on EDGAR →This press release announces a development agreement between Cespira (Westport's joint venture with Volvo Group) and Volvo Group to finalize hydrogen-fueled engine development using Cespira's HPDI™ fuel system technology. The disclosure describes a material strategic partnership milestone—extending proven LNG technology to hydrogen applications with a targeted commercial launch before 2030—that would affect a reasonable investor's assessment of Westport's technology roadmap and market opportunities, but does not fit the specific categories of M&A activity, earnings, executive changes, or financial obligations.
View raw filing on EDGAR →This press release announces positive exploration drill results from Endeavour Silver's Terronera mine in Mexico, disclosing high-grade silver and gold mineralization intersections (e.g., LL-43: 574 g/t Ag, 23.92 g/t Au; TRU-001: 282 g/t Ag, 1.80 g/t Au). The company states these results "demonstrate the exploration potential" and highlight "the opportunity to grow resources, extend mine life and unlock additional value." While not a formal earnings release, resource expansion and mine-life extension at an operating property are material operational developments affecting investor assessment of the registrant's asset base and future production capacity.
View raw filing on EDGAR →This press release discloses Anfield Energy's filing of an updated Preliminary Economic Assessment (PEA) for its uranium and vanadium mining projects. The PEA projects a pre-tax IRR of 106% and NPV of US$606 million, with estimated annual production of 1.3 million pounds of uranium and 6.4 million pounds of vanadium over a 15-year mine life. This is a material operational and strategic milestone for a development-stage mining company, reflecting the technical and economic viability of its hub-and-spoke production model centered on the Shootaring Mill. While not a traditional earnings release or M&A event, the PEA represents a significant operational development that would affect a reasonable investor's assessment of the company's path to commercial production and asset value.
View raw filing on EDGAR →This press release discloses material operational challenges and revised production guidance for Alamos Gold's Canadian operations. The Young-Davidson mine experienced seismic events that damaged infrastructure and limited access to higher-grade stopes, plus unplanned power outages, resulting in revised Q2 production guidance of 130,000–135,000 ounces (a 12% decrease from prior guidance) and expected full-year production below the low end of 2026 guidance. While the Island Gold District remains on track, the operational disruptions and significant downward revision to consolidated production and cost guidance would materially affect a reasonable investor's assessment of the registrant's near-term performance and 2026 outlook.
View raw filing on EDGAR →